Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients

Molecular Profiling of Colon Tumors: The Search for Clinically Relevant Biomarkers of Progression, Prognosis, Therapeutics, and Predisposition

(2011) Manny D. Bacolod et al.   ANNALS OF SURGICAL ONCOLOGY

Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer

(2011) Hitoshi Ohmori et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

HMGB1 and RAGE in Inflammation and Cancer

(2010) Gary P. Sims et al.   Annual Review of Immunology

High-mobility group box 1 and cancer

(2010) Daolin Tang et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer

(2010) Rui-Qing Peng et al.   BMC CANCER

Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance

(2010) Yong Liu et al.   EUROPEAN JOURNAL OF CANCER

HMGB1 release and redox regulates autophagy and apoptosis in cancer cells

(2010) D Tang et al.   ONCOGENE

Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas

(2010) Guoqiang Bao et al.   World Journal of Surgical Oncology

Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma

(2009) Xingjun Yao et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer

(2009) Hye Chung et al.   Journal of Translational Medicine

Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma

(2009) Seung-Kuk Baek et al.   LARYNGOSCOPE

Molecular Interactions between Dying Tumor Cells and the Innate Immune System Determine the Efficacy of Conventional Anticancer Therapies

(2008) L. Apetoh et al.   CANCER RESEARCH

Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma

(2008) D Wu et al.   JOURNAL OF PATHOLOGY